ID   G2 [Human leukemia]
AC   CVCL_R868
DR   Wikidata; Q54835382
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1531243;
RX   PubMed=7845014;
CC   Doubling time: 72 hours (PubMed=1531243).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=1531243;
RA   Kamel-Reid S., Dick J.E., Greaves A., Murdoch B., Doedens M.,
RA   Grunberger T., Thorner P.S., Freedman M.H., Phillips R.A., Letarte M.;
RT   "Differential kinetics of engraftment and induction of CD10 on human
RT   pre-B leukemia cell lines in immune deficient scid mice.";
RL   Leukemia 6:8-17(1992).
//
RX   PubMed=7845014;
RA   Ishii E., Greaves A., Grunberger T., Freedman M.H., Letarte M.;
RT   "Tumor formation by a human pre-B leukemia cell line in scid mice is
RT   enhanced by matrigel and is associated with induction of CD10
RT   expression.";
RL   Leukemia 9:175-184(1995).
//